Insights on multiple myeloma treatment strategies
Palabras clave : 
Myeloma
Treatment Strategies
Therapies
Biomarkers
Delay progression
Fecha de publicación : 
2018
Editorial : 
Ovid Technologies (Wolters Kluwer Health)
ISSN : 
2572-9241
Nota: 
This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cita: 
Mateos, M.V. (María Victoria); Ludwig, H. (Heinz); Bazarbachi, A. (Ali); et al. "Insights on multiple myeloma treatment strategies". HemaSphere. 3 (1), 2018, e163
Resumen
The introduction of new agents and management strategies over the past decade has resulted in a major step change in treatment outcomes with deepening responses and increased survival for patients with multiple myeloma. In daily clinical practice, healthcare professionals are now faced with challenges including, optimal treatment sequencing and changing treatment goals. In light of this, a group of experts met to discuss diagnostic and treatment guidelines, examine current clinical practice, and consider how new clinical trial data may be integrated into the management of multiple myeloma in the future.

Ficheros en este ítem:
Vista previa
Fichero
Insights_on_Multiple_Myeloma_Treatment_Strategies.7.pdf
Descripción
Tamaño
4.42 MB
Formato
Adobe PDF


Estadísticas e impacto
0 citas en
0 citas en

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.